backHealthcare M&A deals have come under increasing scrutiny in recent years. A number of state legislatures have proposed or enacted new laws to require parties to transactions involving acquisitions and other investments in healthcare providers to submit transactions to regulators for review prior to closing. Some of these laws require the parties to submit public filings that disclose financial and operational details regarding the parties and any private equity sponsors or other upstream investors involved in the transaction. The FTC and state antitrust regulators have also stepped up their efforts to review healthcare M&A deals. Regulatory reviews can significantly impact the closing timeline for transactions and can also create uncertainty regarding the ability to close in states where regulators are given discretion to block transactions. Please join us for a roundtable webinar on June 20, 2023, from 1:00 P.M. to 2:00 P.M. where our panel will explore these issues. Specifically, the panel will explore:
- Newly-passed legislation requiring regulatory review of healthcare transactions
- Other efforts to impose regulatory review requirements for healthcare deals
- Potential impact on healthcare M&A trends
- Strategies for navigating licensure and change of ownership (CHOW) requirements